1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 31 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy malesWu, T.; Rayner, C.; Watson, L.; Jones, K.; Horowitz, M.; Little, T.
2020Effects of sitagliptin on gastric emptying of, and the glycaemic and blood pressure responses to, a carbohydrate meal in type 2 diabetesStevens, J.; Buttfield, M.; Wu, T.; Hatzinikolas, S.; Pham, H.; Lange, K.; Rayner, C.; Horowitz, M.; Jones, K.
2014Changes in meal composition and duration affect postprandial endothelial function in healthy humansThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Jones, K.; Willoughby, S.; Horowitz, M.; Rayner, C.
2015Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?Wu, T.; Trahair, L.; Bound, M.; Deacon, C.; Horowitz, M.; Rayner, C.; Jones, K.
2016Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: a randomised controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2016The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trialThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Crouch, B.; Jones, K.; Horowitz, M.; Rayner, C.
2016Regional specificity of the gut-incretin response to small intestinal glucose infusion in healthy older subjectsRigda, R.; Trahair, L.; Little, T.; Wu, T.; Standfield, S.; Feinle-Bisset, C.; Rayner, C.; Horowitz, M.; Jones, K.
2016Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.

Discover